Peroxisome proliferator-activated receptor delta

From WikiMD's Food, Medicine & Wellness Encyclopedia

Peroxisome proliferator-activated receptor delta (PPAR-δ), also known as PPARD, is a protein that in humans is encoded by the PPARD gene. It is a member of the peroxisome proliferator-activated receptors (PPARs) family, which are nuclear receptor proteins that function as transcription factors regulating the expression of genes.

Function[edit | edit source]

PPAR-δ is involved in many biological processes, including lipid metabolism, glucose homeostasis, inflammation, and wound healing. It plays a crucial role in the regulation of fatty acid oxidation, energy metabolism, and insulin sensitivity. PPAR-δ activation has been shown to increase HDL cholesterol and decrease triglycerides levels in the blood.

Clinical significance[edit | edit source]

PPAR-δ has been implicated in several diseases, including obesity, diabetes, atherosclerosis, and cancer. It is a potential therapeutic target for the treatment of metabolic diseases and certain types of cancer. Several PPAR-δ agonists are currently under investigation for their potential therapeutic effects.

Structure[edit | edit source]

The PPAR-δ protein consists of a DNA-binding domain and a ligand-binding domain. The DNA-binding domain recognizes specific DNA sequences, known as peroxisome proliferator response elements (PPREs), in the promoter region of target genes. The ligand-binding domain binds to specific ligands, leading to the activation of PPAR-δ.

Ligands[edit | edit source]

Several natural and synthetic ligands have been identified for PPAR-δ. Natural ligands include certain fatty acids and their derivatives. Synthetic ligands include drugs such as GW501516 and L-165041.

See also[edit | edit source]

References[edit | edit source]

‎ ‎


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD